Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information system.

Puig-Barberà J, Natividad-Sancho A, Calabuig-Pérez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martínez-Úbeda S, Díez-Domingo J.

Vaccine. 2014 Sep 22;32(42):5447-54. doi: 10.1016/j.vaccine.2014.07.095. Epub 2014 Aug 12.

2.

MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.

Puig-Barberà J, Natividad-Sancho A, Calabuig-Pérez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martínez-Úbeda S, Pérez-Vilar S, Díez-Domingo J.

Vaccine. 2013 Aug 20;31(37):3995-4002. doi: 10.1016/j.vaccine.2013.05.070. Epub 2013 Jun 1.

3.

Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study.

Spadea A, Unim B, Colamesta V, Meneghini A, D'Amici AM, Giudiceandrea B, La Torre G.

Vaccine. 2014 Sep 15;32(41):5290-4. doi: 10.1016/j.vaccine.2014.07.077. Epub 2014 Aug 1.

PMID:
25087677
4.

Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: a one-year prospective cohort study.

Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW.

Vaccine. 2011 Oct 13;29(44):7773-8. doi: 10.1016/j.vaccine.2011.07.112. Epub 2011 Aug 5.

PMID:
21821084
5.

Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.

Gasparini R, Amicizia D, Lai PL, Rossi S, Panatto D.

Hum Vaccin Immunother. 2013 Jan;9(1):144-52. doi: 10.4161/hv.22231. Epub 2012 Nov 10.

6.

Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain.

Puig-Barberà J, García-de-Lomas J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Limón-Ramírez R, Pérez-Vilar S, Micó-Esparza JL, Tortajada-Girbés M, Carratalá-Munuera C, Larrea-González R, Beltrán-Garrido JM, Otero-Reigada Mdel C, Mollar-Maseres J, Correcher-Medina P, Schwarz-Chavarri G, Gil-Guillén V; Valencia Hospital Network for the Study of Influenza and Respiratory Virus Disease.

PLoS One. 2014 Nov 13;9(11):e112294. doi: 10.1371/journal.pone.0112294. eCollection 2014.

7.

Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009.

Phillips CJ, Woolpert T, Sevick C, Faix D, Blair PJ, Crum-Cianflone NF.

Clin Infect Dis. 2013 Jan;56(1):11-9. doi: 10.1093/cid/cis860. Epub 2012 Nov 26.

PMID:
23183869
8.

Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.

Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Saez M, Soldevila N, Astray J, Mayoral JM, Martín V, Quintana JM, González-Candelas F, Galán JC, Tamames S, Castro A, Baricot M, Garín O, Pumarola T; CIBERESP Cases and Controls in Pandemic Influenza Working Group (Spain).

Hum Vaccin Immunother. 2013 Apr;9(4):865-73. doi: 10.4161/hv.23090. Epub 2013 Apr 1.

9.

Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.

Ridenhour BJ, Campitelli MA, Kwong JC, Rosella LC, Armstrong BG, Mangtani P, Calzavara AJ, Shay DK.

PLoS One. 2013 Oct 16;8(10):e76318. doi: 10.1371/journal.pone.0076318. eCollection 2013.

10.

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study.

Martínez-Baz I, Martínez-Artola V, Reina G, Guevara M, Cenoz MG, Morán J, Irisarri F, Arriazu M, Albeniz E, Castilla J; Primary Health Care Sentinel Network of Navarre.

BMC Public Health. 2013 Mar 6;13:191. doi: 10.1186/1471-2458-13-191.

11.

Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study.

Wang IK, Lin CL, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Morisky DE, Huang CC, Sung FC.

PLoS One. 2013;8(3):e58317. doi: 10.1371/journal.pone.0058317. Epub 2013 Mar 13.

12.

Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.

Ansaldi F, Orsi A, de Florentiis D, Parodi V, Rappazzo E, Coppelli M, Durando P, Icardi G.

Hum Vaccin Immunother. 2013 Mar;9(3):591-8. Epub 2013 Jan 7.

13.

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.

McElhaney JE, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, Ruiz-Palacios GM, van Essen GA, Caplanusi A, Claeys C, Durand C, Duval X, El Idrissi M, Falsey AR, Feldman G, Frey SE, Galtier F, Hwang SJ, Innis BL, Kovac M, Kremsner P, McNeil S, Nowakowski A, Richardus JH, Trofa A, Oostvogels L; Influence65 study group.

Lancet Infect Dis. 2013 Jun;13(6):485-96. doi: 10.1016/S1473-3099(13)70046-X. Epub 2013 Mar 19.

PMID:
23518156
14.

Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy.

Mannino S, Villa M, Apolone G, Weiss NS, Groth N, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Rothman KJ.

Am J Epidemiol. 2012 Sep 15;176(6):527-33. Epub 2012 Aug 31.

15.

Targeted vaccine selection in influenza vaccination.

Wutzler P, Hardt R, Knuf M, Wahle K.

Dtsch Arztebl Int. 2013 Nov 22;110(47):793-8. doi: 10.3238/arztebl.2013.0793. Review.

16.

Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study.

Castilla J, Martínez-Artola V, Salcedo E, Martínez-Baz I, Cenoz MG, Guevara M, Alvarez N, Irisarri F, Morán J, Barricarte A; Network for Influenza Surveillance in Hospitals of Navarre.

Vaccine. 2012 Jan 5;30(2):195-200. doi: 10.1016/j.vaccine.2011.11.024. Epub 2011 Nov 18.

PMID:
22100636
17.

[Effectiveness of influenza vaccination in preventing hospital admission due to exacerbations of chronic obstructive pulmonary disease].

Montserrat-Capdevila J, Godoy P, Marsal JR, Cruz I, Solanes M.

Enferm Infecc Microbiol Clin. 2014 Feb;32(2):70-5. doi: 10.1016/j.eimc.2013.02.009. Epub 2013 Apr 11. Spanish.

PMID:
23582192
18.

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.

Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT.

BMC Infect Dis. 2015 Oct 27;15:465. doi: 10.1186/s12879-015-1193-4.

19.

Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.

Richardson DM, Medvedeva EL, Roberts CB, Linkin DR; Centers for Disease Control and Prevention Epicenter Program.

Clin Infect Dis. 2015 Jul 15;61(2):171-6. doi: 10.1093/cid/civ261. Epub 2015 Mar 31.

PMID:
25829001
20.

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly.

Foster DA, Talsma A, Furumoto-Dawson A, Ohmit SE, Margulies JR, Arden NH, Monto AS.

Am J Epidemiol. 1992 Aug 1;136(3):296-307.

PMID:
1415151

Supplemental Content

Support Center